Insider Buys Todd Patrick:
3046875 2017-08-09 2017-08-15 Direct Ownership :
10 - Acquisition or disposition in the public market +40,651 2.2000 USD 1,030,214
3046878 2017-08-10 2017-08-15 Direct Ownership :
10 - Acquisition or disposition in the public market +9,349 2.4450 USD 1,039,563
Todd Patrick - Director
Mr. Patrick is the President and Chief Executive Officer of C3J Therapeutics, Inc., a clinical stage biotechnology company based in Los Angeles, California. Prior to joining C3J, Mr. Patrick was the President and Chief Operating Officer of ID Biomedical Corporation. Mr. Patrick was with ID Biomedical from 1994 until 2005 when the company was acquired by GlaxoSmithKline. Prior to ID Biomedical, Mr. Patrick was the Director of the Office of Intellectual Property Administration at the University of California, Los Angeles (UCLA), where he was responsible for the patenting and licensing of intellectual property arising out of UCLA. Mr. Patrick holds a B.A. (Economics) from the University of Washington and a Master’s in Business Administration from Washington State University.
Mr. Patrick has been a director of the Company since May 2006.
Member of: Audit Committee, Corporate Governance & Nominating Committee, Compensation Committee